Novo Nordisk Spokesperson Says Pfizer's Claims That Novo Nordisk Intends To Suppress Innovation Through Our Offer Is "False And Without Merit"; Offer For Metsera Highlights Co's Commitment To Investing In The U.S.
Author: Benzinga Newsdesk | November 03, 2025 11:52am